Supply Issues Medicina Ltd Oral Tip Syringes FTA374 and FTA286 (ICN 3182)

Change:

• The supplier Medicina Limited has informed us of a supply issue with its Oral Tip Syringes.
• Two product codes are affected:
  • FTA374 – Oral Tip Syringe 1ml purple – reusable – unwinged – individually wrapped – centered
  • FTA286 – Oral Tip Syringe 1ml purple – single use – unwinged – individually wrapped sterile – centered.
• The supply issue is due to increased demand and lead times.

Impact:          

• FTA374 is currently suspended and unavailable to order.
• FTA286 is still available while our remaining stock lasts. One depleted it will then be suspended and unavailable to order.
• Potential indirect alternative products are available to order through our online catalogue:
  • FTA343 – Oral Tip Syringe 1ml lilac – single use – unwinged – individually wrapped sterile – centered
  • FMG85006 – Oral Tip Syringe 1ml Dispensing Purple Plunger with cap
  • FMG85004 – Oral Tip Syringe 1ml Dispensing Amber with cap.
• Please be advised alternatives may require a change in size (from 1ml to 2.5ml) and a change from reuseable to single use.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives.
• The supply issue is anticipated to be resolved by 9 February 2026.

Next Steps:               

• Customers are advised to log into our website to view the product listing for further information on the affected product codes and potential alternatives.
• When choosing an alternative please factor in single use versus reuseable, size and colour.
• The continuing supply issue is being monitored in conjunction with the supplier, and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.